Cargando…

The Significance of Serum HER2 Levels at Diagnosis on Intrinsic Subtype-Specific Outcome of Operable Breast Cancer Patients

PURPOSE: This study evaluated the association of serum HER2 (sHER2) levels at diagnosis with clinicopathologic parameters and disease free survival (DFS) in operable breast cancer patients according to intrinsic subtype. METHODS: The sHER2 levels were measured using a chemiluminescence immunoassay....

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Moo Hyun, Jung, So-Youn, Kang, Sun Hee, Song, Eun Jin, Park, In Hae, Kong, Sun-Young, Kwon, Young Mee, Lee, Keun Seok, Kang, Han-Sung, Lee, Eun Sook
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5051717/ https://www.ncbi.nlm.nih.gov/pubmed/27706242 http://dx.doi.org/10.1371/journal.pone.0163370

Ejemplares similares

Integrative In Vivo Drug Testing Using Gene Expression Signature and Patient-Derived Xenografts from Treatment-Refractory HER2 Positive and Triple-Negative Subtypes of Breast Cancer
por: Ryu, Jin-Sun, et al.
Publicado: (2019)

Impact of Molecular Subtype Conversion of Breast Cancers after Neoadjuvant Chemotherapy on Clinical Outcome
por: Lim, Siew Kuan, et al.
Publicado: (2016)

Protein and lipid MALDI profiles classify breast cancers according to the intrinsic subtype
por: Kang, Han Sung, et al.
Publicado: (2011)

Androgen Receptor as a Predictive Marker for Pathologic Complete Response in Hormone Receptor–Positive and HER-2–Negative Breast Cancer with Neoadjuvant Chemotherapy
por: Lee, Eun-Gyeong, et al.
Publicado: (2023)

Upregulated HSP27 in human breast cancer cells reduces Herceptin susceptibility by increasing Her2 protein stability
por: Kang, Se Hun, et al.
Publicado: (2008)

Clinicopathological Factors Associated with Oncotype DX Risk Group in Patients with ER+/HER2- Breast Cancer
por: Song, Ran, et al.
Publicado: (2023)

Outcomes of Pregnancy after Breast Cancer in Korean Women: A Large Cohort Study
por: Lee, Moo Hyun, et al.
Publicado: (2020)

Intrinsic molecular subtypes of HER2+ breast cancer
por: Prat, Aleix, et al.
Publicado: (2017)

Tumor-derived IL-18 induces PD-1 expression on immunosuppressive NK cells in triple-negative breast cancer
por: Park, In Hae, et al.
Publicado: (2017)

Prognostic Significance of HER3 Expression in Patients with Cervical Cancer
por: Chang, Chi-Son, et al.
Publicado: (2022)

Health Behaviors of Cancer Survivors in Nationwide Cross-Sectional Survey in Korea: Higher Alcohol Drinking, Lower Smoking, and Physical Inactivity Pattern in Survivors with Higher Household Income
por: Park, Boyoung, et al.
Publicado: (2015)

Breast cancer subtypes and survival in patients with brain metastases
por: Nam, Byung-Ho, et al.
Publicado: (2008)

Psychosocial Health of Disease-Free Breast Cancer Survivors Compared with Matched Non-cancer Controls
por: Park, Boyoung, et al.
Publicado: (2019)

CKAP2 (cytoskeleton-associated protein2) is a new prognostic marker in HER2-negative luminal type breast cancer
por: Sim, Sung Hoon, et al.
Publicado: (2017)

The changes of subtypes in pediatric diabetes and their clinical and laboratory characteristics over the last 20 years
por: Kwon, Eun Byul, et al.
Publicado: (2016)

Proposal for a Standardized Pathology Report of Gastroenteropancreatic Neuroendocrine Tumors: Prognostic Significance of Pathological Parameters
por: Cho, Mee-Yon, et al.
Publicado: (2013)

Characteristics of BRCA1/2 mutations carriers including large genomic rearrangements in high risk breast cancer patients
por: Park, Boyoung, et al.
Publicado: (2017)

Predictive biological factors for late survival in patients with HER2-positive breast cancer
por: Kang, Young-Joon, et al.
Publicado: (2023)

Clinical impact of follow‐up imaging on mortality in Korean breast cancer patients: A national cohort study
por: Jung, So‐Youn, et al.
Publicado: (2021)

Sentinel Lymph Node Biopsy in Breast Cancer Patients With Pathological Complete Response in the Axillary Lymph Node After Neoadjuvant Chemotherapy
por: Kim, Hyunhee, et al.
Publicado: (2021)

Targeted next generation sequencing of circulating tumor DNA provides prognostic information for management in breast cancer patients
por: Shim, Hyoeun, et al.
Publicado: (2022)

Interaction Effect Between Breast Density and Reproductive Factors on Breast Cancer Risk in Korean Population
por: Lim, Se-Eun, et al.
Publicado: (2019)

Single-molecule functional anatomy of endogenous HER2-HER3 heterodimers
por: Choi, Byoungsan, et al.
Publicado: (2020)

The Role of Chemotherapy in Patients With HER2-Negative Isolated Locoregional Recurrence of Breast Cancer: A Multicenter Retrospective Cohort Study
por: Lee, Kyoungmin, et al.
Publicado: (2021)

Antibody-Based Targeting of Interferon-Beta-1a Mutein in HER2-Positive Cancer Enhances Antitumor Effects Through Immune Responses and Direct Cell Killing
por: Lee, Chan Gyu, et al.
Publicado: (2021)

EpCAM expression varies significantly and is differentially associated with prognosis in the luminal B HER2(+), basal-like, and HER2 intrinsic subtypes of breast cancer
por: Soysal, S D, et al.
Publicado: (2013)

Recurrent Glioblastomas Reveal Molecular Subtypes Associated with Mechanistic Implications of Drug-Resistance
por: Kwon, So Mee, et al.
Publicado: (2015)

Alu and LINE-1 Hypomethylation Is Associated with HER2 Enriched Subtype of Breast Cancer
por: Park, So Yeon, et al.
Publicado: (2014)

Impact of HIV-1 subtype and Korean Red Ginseng on AIDS progression: comparison of subtype B and subtype D
por: Cho, Young-Keol, et al.
Publicado: (2019)

Prognostic Significance of a Complete Response on Breast MRI in Patients Who Received Neoadjuvant Chemotherapy According to the Molecular Subtype
por: Ko, Eun Sook, et al.
Publicado: (2015)

Prognostic Significance of Defining L-Cell Type on the Biologic Behavior of Rectal Neuroendocrine Tumors in Relation with Pathological Parameters
por: Sohn, Jin Hee, et al.
Publicado: (2015)

Determining the Factors Predicting the Response to Anti-HER2 Therapy in HER2-Positive Breast Cancer Patients
por: You, Ji Young, et al.
Publicado: (2023)

HSP90 inhibitor, AUY922, debilitates intrinsic and acquired lapatinib-resistant HER2-positive gastric cancer cells
por: Park, Kang-Seo, et al.
Publicado: (2018)

Development of multifocal nodular lesions of a liver mimicking hepatic metastasis, following resection of an insulinoma in a child
por: Jung, Sook Young, et al.
Publicado: (2015)

Geographic differences in the epidemiological features of HCV infection in Korea
por: Kim, Kyung-Ah, et al.
Publicado: (2014)

Two distinct stem cell‐like subtypes of hepatocellular carcinoma with clinical significance and their therapeutic potentials
por: Lee, Sung Hwan, et al.
Publicado: (2022)

Breast Cancer–Related Lymphedema after Neoadjuvant Chemotherapy
por: Kim, Myungsoo, et al.
Publicado: (2015)

High Expression of NRF2 and Low Expression of KEAP1 Predict Worse Survival in Patients With Operable Triple-Negative Breast Cancer
por: Lee, Young Sub, et al.
Publicado: (2023)

Malignancy Risk and Related Factors of Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance in Thyroid Fine Needle Aspiration
por: Hong, So-hyeon, et al.
Publicado: (2018)

Clinically Significant Unclassified Variants in BRCA1 and BRCA2 genes among Korean Breast Cancer Patients
por: Yoon, Kyong-Ah, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_6esddqek9c8p3l8f3mguco0t4l